Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 95

Similar articles for PubMed (Select 25072694)

1.

Antisense-mediated Exon Skipping Decreases Tau Protein Expression: A Potential Therapy For Tauopathies.

Sud R, Geller ET, Schellenberg GD.

Mol Ther Nucleic Acids. 2014 Jul 29;3:e180. doi: 10.1038/mtna.2014.30.

2.

Alternative splicing of exon 10 in the tau gene as a target for treatment of tauopathies.

Zhou J, Yu Q, Zou T.

BMC Neurosci. 2008 Dec 3;9 Suppl 2:S10. doi: 10.1186/1471-2202-9-S2-S10. Review.

3.

MAPT isoforms: differential transcriptional profiles related to 3R and 4R splice variants.

Chen S, Townsend K, Goldberg TE, Davies P, Conejero-Goldberg C.

J Alzheimers Dis. 2010;22(4):1313-29. doi: 10.3233/JAD-2010-101155.

4.

Haplotype-specific expression of exon 10 at the human MAPT locus.

Caffrey TM, Joachim C, Paracchini S, Esiri MM, Wade-Martins R.

Hum Mol Genet. 2006 Dec 15;15(24):3529-37. Epub 2006 Nov 3.

5.

Clinicopathologic assessment and imaging of tauopathies in neurodegenerative dementias.

Murray ME, Kouri N, Lin WL, Jack CR Jr, Dickson DW, Vemuri P.

Alzheimers Res Ther. 2014 Jan 2;6(1):1. doi: 10.1186/alzrt231. eCollection 2014. Review.

6.

Current advances on different kinases involved in tau phosphorylation, and implications in Alzheimer's disease and tauopathies.

Ferrer I, Gomez-Isla T, Puig B, Freixes M, Ribé E, Dalfó E, Avila J.

Curr Alzheimer Res. 2005 Jan;2(1):3-18. Review.

PMID:
15977985
7.

Knock-out and transgenic mouse models of tauopathies.

Denk F, Wade-Martins R.

Neurobiol Aging. 2009 Jan;30(1):1-13. Epub 2007 Jun 22. Review.

8.

The role of tau (MAPT) in frontotemporal dementia and related tauopathies.

Rademakers R, Cruts M, van Broeckhoven C.

Hum Mutat. 2004 Oct;24(4):277-95. Review.

PMID:
15365985
9.

Exon 3 insert of tau protein in neurodegenerative diseases.

Terada S, Ishizu H, Ishiguro K, Tanabe Y, Itoh N, Yasutake K, Furubayashi A, Kitamura Y, Kuroda S.

Acta Neuropathol. 2005 Jul;110(1):12-8. Epub 2005 May 26.

PMID:
15918074
10.
11.

Pathological inclusion bodies in tauopathies contain distinct complements of tau with three or four microtubule-binding repeat domains as demonstrated by new specific monoclonal antibodies.

de Silva R, Lashley T, Gibb G, Hanger D, Hope A, Reid A, Bandopadhyay R, Utton M, Strand C, Jowett T, Khan N, Anderton B, Wood N, Holton J, Revesz T, Lees A.

Neuropathol Appl Neurobiol. 2003 Jun;29(3):288-302.

PMID:
12787326
12.

Genetic bases of Progressive Supranuclear Palsy: the MAPT tau disease.

Borroni B, Agosti C, Magnani E, Di Luca M, Padovani A.

Curr Med Chem. 2011;18(17):2655-60. Review.

PMID:
21568901
13.

A genomic sequence analysis of the mouse and human microtubule-associated protein tau.

Poorkaj P, Kas A, D'Souza I, Zhou Y, Pham Q, Stone M, Olson MV, Schellenberg GD.

Mamm Genome. 2001 Sep;12(9):700-12.

PMID:
11641718
14.

[Neuropathology of tauopathy].

Yoshida M.

Brain Nerve. 2013 Dec;65(12):1445-58. Review. Japanese.

PMID:
24323931
15.

Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons.

Padmanabhan J, Levy M, Dickson DW, Potter H.

Brain. 2006 Nov;129(Pt 11):3020-34. Epub 2006 Sep 20.

16.

Tau nitration occurs at tyrosine 29 in the fibrillar lesions of Alzheimer's disease and other tauopathies.

Reynolds MR, Reyes JF, Fu Y, Bigio EH, Guillozet-Bongaarts AL, Berry RW, Binder LI.

J Neurosci. 2006 Oct 18;26(42):10636-45.

17.

Stimulation of autophagy is neuroprotective in a mouse model of human tauopathy.

Schaeffer V, Goedert M.

Autophagy. 2012 Nov;8(11):1686-7. doi: 10.4161/auto.21488. Epub 2012 Aug 9.

18.

Novel drugs affecting tau behavior in the treatment of Alzheimer's disease and tauopathies.

Navarrete LP, Pérez P, Morales I, Maccioni RB.

Curr Alzheimer Res. 2011 Sep;8(6):678-85. Review.

PMID:
21605038
19.

Reprogramming of tau alternative splicing by spliceosome-mediated RNA trans-splicing: implications for tauopathies.

Rodriguez-Martin T, Garcia-Blanco MA, Mansfield SG, Grover AC, Hutton M, Yu Q, Zhou J, Anderton BH, Gallo JM.

Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15659-64. Epub 2005 Oct 17.

20.

Neurodegeneration and defective neurotransmission in a Caenorhabditis elegans model of tauopathy.

Kraemer BC, Zhang B, Leverenz JB, Thomas JH, Trojanowski JQ, Schellenberg GD.

Proc Natl Acad Sci U S A. 2003 Aug 19;100(17):9980-5. Epub 2003 Jul 18.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk